1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

CHI Announces Pre-Registrant List for the 3rd Annual Oncology Clinical Trials

CHI’s Oncology Clinical Trials: Bringing Effective and Safe Cancer Therapy to Patient will take place Feb. 13-15, 2013 at the Moscone in San Francisco, CA. This conference is part of the Molecular Med TRI-CON 2013. www.triconference.com/cct

 
PRLog - Jan. 16, 2013 - Needham Ma - Attendees of this meeting will hear recent breakthroughs in understanding the molecular biology of cancer have led to an unprecedented number of new targets in oncology drug development. There are more cancer drugs in the research pipeline than any other type of therapy, corresponding directly with the number of oncology clinical trials. Why do phase III clinical trials in oncology fail so often? One simple answer does not exist to this critically important question. Success of an oncology trial depends on many factors: scientific, organizational, biostatistical, regulatory, ethical and economical.  The second annual Oncology Clinical Trials is designed to provide a comprehensive coverage of many of these components as well as present case studies of successful clinical trials.

Just Some of the Companies Already Registered Include:

-Alere San Diego
-Alligator Bioscience AB
-Aptiv Solutions Inc
-ARIAD Pharmaceuticals Inc
-BN ImmunoTherapeutics Inc
-C Almon Consulting LLC
-Cedars Sinai Medical Ctr
-Chemical Abstracts Svc
-CINJ
-Clovis Oncology
-Colby Pharmaceutical Co
-Cytel Inc
-Daiichi Sankyo Taiwan Ltd
-Duke Univ
-Eli Lilly & Co
-F Hoffmann La Roche Inc
-Genentech Inc
-Gilead Sciences Inc
-Gilupi GmbH
-GlaxoSmithKline
-GlycoMimetics Inc
-Greenville Hospital System
-Hannover Clinical Trial Ctr GmbH
-Illumina
-Janssen R&D LLC
-Joint Genome Institute
-Kookmin Univ
-Life Technologies Corp
-MD Anderson Cancer Ctr
-Medivation Inc
-Merck Research Labs
-Merck Serono SA
-Millennium The Takeda Oncology Co
-Nationwide Childrens Hospital
-Natl Cancer Ctr
-NIH NCI
-Onyx Pharmaceuticals Inc
-Pfizer Inc
-RadioR
-Regeneron Pharmaceuticals Inc
-ResearchDx LLC
-Roche Diagnostics
-Roche Diagnostics New Zealand Ltd
-SARC
-Seattle Genetics Inc
-Singulex
-Stanford Univ
-TGen Translational Genomics Research Institute
-Theranostics Health
-Threshold Pharmaceuticals
-Univ of Arkansas for Medical Sciences
-Univ Of Auckland
-Univ of California Los Angeles
-Univ of California San Francisco
-Univ of Michigan
-Univ of Toledo
-Univ of Toronto
-Univ of Washington
-Uppsala Monitoring Ctr

As part of the Molecular Med TRI-CON 2013, attendees have access to a partnering forum, 5 symposia, 18 short courses, and 12 core programs. The event attracts than 3,000 attendees and provides attendees an opportunity to interact with each other in the shared exhibit/poster hall, plenary keynotes and social functions.

Discounts are available until January 18th, 2013.  For complete event details visit: http://www.triconference.com/cct

To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, jstroup@healthtech.com.

Writers and editors are encouraged to attend. To request a press pass, contact Lisa Scimemi at lscimemi@healthtech.com.

About Cambridge Healthtech Institute (www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

--- End ---

Click to Share

Contact Email:
***@healthtech.com Email Verified
Source:Cambridge Healthtech Institute
Phone:781.972.5400
Zip:02494
City/Town:Needham - Massachusetts - United States
Industry:Biotech, Medical
Tags:oncology clinical trials, triconference, san francisco, molecular medicine
Shortcut:prlog.org/12060764
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share